This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (25)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Dementias  • Neurology, Other  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Alert me on articles by topic

The Framingham Heart Study

Ernst J. Schaefer, MD; Vanina Bongard, MD, PhD; Alexa S. Beiser, PhD; Stefania Lamon-Fava, MD, PhD; Sander J. Robins, MD; Rhoda Au, PhD; Katherine L. Tucker, PhD; David J. Kyle, PhD; Peter W. F. Wilson, MD; Philip A. Wolf, MD

Arch Neurol. 2006;63:1545-1550.

Background  Docosahexaenoic acid (DHA) is an abundant fatty acid in the brain. In the diet, DHA is found mostly in fatty fish. The content of DHA has been shown to be decreased in the brain and plasma of patients with dementia.

Objective  To determine whether plasma phosphatidylcholine (PC) DHA content is associated with the risk of developing dementia.

Design, Setting, and Participants  A prospective follow-up study in 899 men and women who were free of dementia at baseline, had a median age of 76.0 years, and were followed up for a mean of 9.1 years for the development of all-cause dementia and Alzheimer disease.

Main Outcome Measures  Plasma PC fatty acid levels were measured at baseline. Cox proportional regression analysis was used to assess relative risks of all-cause dementia and Alzheimer disease according to baseline plasma levels.

Results  Ninety-nine new cases of dementia (including 71 of Alzheimer disease) occurred during the follow-up. After adjustment for age, sex, apolipoprotein E 4 allele, plasma homocysteine concentration, and education level, subjects in the upper quartile of baseline plasma PC DHA levels, compared with subjects in the lower 3 quartiles, had a relative risk of 0.53 of developing all-cause dementia (95% confidence interval, 0.29-0.97; P=.04) and 0.61 of developing Alzheimer disease (95% confidence interval, 0.31-1.18; P=.14). Subjects in the upper quartile of plasma PC DHA levels had a mean DHA intake of 0.18 g/d and a mean fish intake of 3.0 servings per week (P<.001) in a subset of 488 participants. We found no other significant associations.

Conclusion  The top quartile of plasma PC DHA level was associated with a significant 47% reduction in the risk of developing all-cause dementia in the Framingham Heart Study.

Author Affiliations: Lipid Metabolism Laboratory (Drs Schaefer, Bongard, and Lamon-Fava) and Dietary Assessment and Epidemiology Program (Dr Tucker), Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Department of Biostatistics, Boston University School of Public Health (Dr Beiser), and Department of Endocrinology, Nutrition, and Diabetes (Dr Robins) and Department of Neurology (Drs Au and Wolf), Boston University School of Medicine, Boston, Mass; Martek Biosciences Corporation, Columbia, Md (Dr Kyle); and Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass (Drs Wilson and Wolf).

RELATED ARTICLE

Docosahexaenoic Acid and Alzheimer Disease
Martha Clare Morris
Arch Neurol. 2006;63(11):1527-1528.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial
van de Rest et al.
Neurology 2008;71:430-438.
ABSTRACT | FULL TEXT  

Electrophilic Cyclopentenone Neuroprostanes Are Anti-inflammatory Mediators Formed from the Peroxidation of the {omega}-3 Polyunsaturated Fatty Acid Docosahexaenoic Acid
Musiek et al.
J. Biol. Chem. 2008;283:19927-19935.
ABSTRACT | FULL TEXT  

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
Vedin et al.
Am. J. Clin. Nutr. 2008;87:1616-1622.
ABSTRACT | FULL TEXT  

Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
Bousquet et al.
FASEB J. 2008;22:1213-1225.
ABSTRACT | FULL TEXT  

Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants
Innis and Friesen
Am. J. Clin. Nutr. 2008;87:548-557.
ABSTRACT | FULL TEXT  

Dietary Polyunsaturated Fat that Is Low in (n-3) and High in (n-6) Fatty Acids Alters the SNARE Protein Complex and Nitrosylation in Rat Hippocampus
Pongrac et al.
J. Nutr. 2007;137:1852-1856.
ABSTRACT | FULL TEXT  

Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-{beta} and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
Green et al.
J. Neurosci. 2007;27:4385-4395.
ABSTRACT | FULL TEXT  

The importance of fish and docosahexaenoic acid in Alzheimer disease
Connor and Connor
Am. J. Clin. Nutr. 2007;85:929-930.
FULL TEXT  

Relationship of vascular risk to the progression of Alzheimer disease
Borroni et al.
Neurology 2007;68:1083-1084.
FULL TEXT  

Docosahexaenoic Acid and Alzheimer Disease
Morris
Arch Neurol 2006;63:1527-1528.
FULL TEXT